Article: CancerVax Announces Retrospective Analyses of Phase 2 Data on Its Investigational Agent Canvaxin in the Treatment of Patients with Stage IV Melanoma.

Article: Celebrities Join Design-her Gals(TM) to Kick Off 2nd ...
Cancer Weekly;  October 14, 2008 ;     700+ words ... ... profit organization dedicated to raising funds and awareness for Stage IV breast cancer patients and their families. Design-her Gals ... Gal Foundation which assists patients and families battling stage IV breast cancer. These initiatives include: The chance for ...

Article: Design-her Gals(TM) Announces the Ground-Breaking Virtual ...
PR Newswire;  November 6, 2007 ;     650 words ... ... continue to make "virtual" history as they announce their "walk for wishes" campaign to grant dreams this holiday season for Stage IV breast cancer patients and their families through the Gal to Gal Foundation, the non-profit organization dedicated to raising ...

Article: Published Data Indicate CancerVax's CANVAXIN Vaccine Increased ...
Business Wire;  January 3, 2003 ;     700+ words ... ... experimental CANVAXIN(TM) therapeutic cancer ... significantly in patients with Stage IV melanoma. The research ... clinically detectable AJCC Stage IV melanoma, 150 received ... with the CANVAXIN(TM) vaccine (treated ... received the CANVAXIN(TM) vaccine (38 vs ... with Stage III and ...

Article: AVAX Technologies' M-Vax Reported to Prolong Survival in Resected ...
PR Newswire;  November 13, 2000 ;     700+ words ... ... Cell technology (AC Vaccine(TM)) that attempts to stimulate ... s lead product, M-Vax(TM), is currently on the market ... melanoma and a Phase 2 trial in Stage IV melanoma. AVAX is also conducting ... Myelogenous Leukemia (L-VAX(TM)) at M.D. Anderson Cancer ...

Article: Maxim Announces Preliminary Results of Two Additional Clinical ...
Business Wire;  June 23, 2003 ;     700+ words ... ... lead drug candidate Ceplene(TM) (histamine dihydrochloride ... the treatment of patients with Stage IV malignant melanoma. Results ... Ceplene for the treatment of Stage IV malignant melanoma in Europe ... included in the M01 Phase 3 study. Stage IV malignant melanoma is the most ...

Article: Melanoma trial shows value of surgery at stage IV: ...
Skin & Allergy News;  May 1, 2006 ;     700+ words ... ... trial has shown promise for surgery in stage IV melanoma. Investigators stopped recruiting ... reported. All had received surgery for stage IV disease before entering the trial, which ... widespread use of surgery is indicated in stage IV melanoma," said Dr. Morton, medical ...

Article: A Stage IV Malignant Melanoma Drug That Increases ...
PR Newswire;  January 19, 2009 ;     700+ words ... ... Resources' Clinical Gold Standard for Stage IV Malignant Melanoma in 2012, According ... issues, finds that a drug for treating stage IV malignant melanoma that can increase median ... new report entitled Malignant Melanoma (Stage IV): Emerging Therapies Must Increase Overall ...